Spot Light: $BEAM

Spot Light: $BEAM

Beam Therapeutics, a highly differentiated, $5.6 billion gene editor that is pioneering a new evolution of gene editing techniques that could be the key to making safer genomic medicines.

Performance Since research:

Nirnaeth
Nirnaeth